Irina Tskhomelidze Schumacher
Biographic Data
| ID | 7799412 |
|---|---|
| NAME | Irina Tskhomelidze Schumacher |
| GIVEN NAMES | Irina Tskhomelidze |
| FAMILY NAME | Schumacher |
| SIGNATURE | SCHUMACHER I T |
| AFFILIATIONS | The Task Force for Global Health |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2026 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Cost and cost-effectiveness of alternative screening and diagnostic pathways for achieving hepatitis C elimination in the country of Georgia
We evaluated the cost and cost-effectiveness of alternative screening pathways during 2018–2022 within Georgia’s hepatitis C elimination program, which started in 2015. We calculated patient-level costs (2022 USD$) of hepatitis C treatment with centralized and decentralized diagnostic testing in hospitals, primary healthcare (PHC), harm reduction providers (HRP), or specialized providers (SP) from reimbursement records including the value of dona…
Results of the HCV self-testing implementation study through the secondary distribution of HCV self-tests among adult males in Georgia
Scaling up hepatitis C virus (HCV) testing and diagnosis is a critical goal of the Global WHO elimination strategy. HCV self-testing (HCVST) has emerged as a promising self-care approach to improve access and early detection, particularly among hard-to-reach populations. In Georgia, a 2015 HCV serosurvey indicated that 57.3% of anti-HCV reactive individuals were men aged 30–59. This study evaluated a secondary distribution strategy for HCVST aime…
No prominent works on this page.
Cost and cost-effectiveness of alternative screening and diagnostic pathways for achieving hepatitis C elimination in the country of Georgia
We evaluated the cost and cost-effectiveness of alternative screening pathways during 2018–2022 within Georgia’s hepatitis C elimination program, which started in 2015. We calculated patient-level costs (2022 USD$) of hepatitis C treatment with centralized and decentralized diagnostic testing in hospitals, primary healthcare (PHC), harm reduction providers (HRP), or specialized providers (SP) from reimbursement records including the value of dona…
Results of the HCV self-testing implementation study through the secondary distribution of HCV self-tests among adult males in Georgia
Scaling up hepatitis C virus (HCV) testing and diagnosis is a critical goal of the Global WHO elimination strategy. HCV self-testing (HCVST) has emerged as a promising self-care approach to improve access and early detection, particularly among hard-to-reach populations. In Georgia, a 2015 HCV serosurvey indicated that 57.3% of anti-HCV reactive individuals were men aged 30–59. This study evaluated a secondary distribution strategy for HCVST aime…
Hepatitis C (2 works) · Hepatitis C virus (2 works) · Hepatitis C virus research (2 works) · Public health (2 works) · Biostatistics (1 works) · Cross-sectional study (1 works) · Diabetes Management and Education (1 works) · Epidemiology (1 works) · Health care (1 works) · Hepatitis (1 works)